Enterotoxigenic E. coli colonization factor antigen (CFA/II)-loaded polyisobutylcyanoacrylate nanoparticles for oral immunization

S.T.P. Pharma Sciences

Volumn 13, Issue 2, 2003, Pages 93-98

  Al Kassas, R S ^a   Rezk, N J ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adsorption; CFA II; Enterotoxigenic E. coli; Oral immunization; Polyisobutylcyanoacrylate nanoparticles

Indexed keywords

BUCRILATE; BUFFER; DODECYL SULFATE SODIUM; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NANOPARTICLE; PHOSPHATE; POLYVINYL ALCOHOL; VACCINE;

ADSORPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; MALE; NONHUMAN; POLYMERIZATION; RABBIT;

EID: 0037345004     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. POWEL F.- Drug delivery issue in vaccine development. - Pharm. Res., 13, 1777-1785, 1996.
2. VENKATASAN V., VYAS S.- Polysaccharide coated liposomes for oral immunization development and characterization. - Int. J. Pharm., 203, 169-177, 2000.
3. MESTECKY J., MALDOVEANU Z., MICHALEK S. et al. - Current options for vaccine delivery systems by mucosal routes. - J. Control. Rel., 48, 243-257, 1996.
4. NAKAMURA M., YAMASHITA S., TSUME Y., et al. - Potential efficacy of gelatin microspheres as a new adjuvant for oral vaccination. - STP Pharm. Sci., 8, 67-73, 1998.
5. BENOIT M., BARAS B., GILLARD J.- Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery. - Int. J. Pharm., 184, 73-84, 1999.
6. LEE V., YAMAMOTO A. - Preparation and enzymatic barrier to peptide and protein absorption. - Adv. Drug Delivery Rev., 4, 171-207, 1990.
7. ALVING C.- Liposomes as carrier for vaccines. - In: Liposomes: From Biophysics to Therapeutics, Ostro M.J. Ed., Marcel Dekker, New York, pp. 195-218.
8. JUNG T., KAMM W., BREITENBACH A., HUNGERER KD., HUNDT E., KISSEL T. - Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft poly(lactide-coglycolide): evaluation of antibody response after oral and nasal application in mice. - Pharm. Res., 18, 352-360, 2001.
9. TOBIO M., GREF R., SANCHEZ A., LANGER R., ALONSO M. - Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. - Pharm. Res., 15, 270-275, 1998.
10. ELDRIDGE J., HAMMOND C., MEULBROEK J., STAAS J., GILLY R., Tice T. - Controlled vaccine release in the gut associated lymph tissue. 1. Orally administered biodegradable microspheres target the Peyer's Patches. - J. Control. Rel., 11, 205-214, 1990.
11. AUDRAN R., MEN Y., JOHANSEN P., GANDER B., CORRADIAN G. - Enhanced innunogenicity of microencapsulated tetanus toxoid with stabilizing agents. - Pharm. Res., 15, 1111-1116, 1998.
12. DONBROW M. - Microcapsules and Nanoparicles in Medicine and Pharmacy. - CRC Press, Boca Raton, 1991.
13. LOSA C., MARCHAL-HUSSLER L., ORALLO F., VILLA JATO J., ALONSO M. - Design of new formulations for topical ocular administration: polymeric nanoparticles containing metipranolol. - Pharm. Res., 10, 80-87, 1993.
14. BLACK R., BROWN K., BECKER S., ALIM ADUF A., HUG I. - Longitudinal studies of infectious diseases and physical growth in children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. - Am. J. Epidemiol., 115, 315-324, 1982.
15. SACK R. - Traveler's diarrhea: microbiological basis for prevention and treatment. - Rev. Infect. Dis., 12,559-563, 1990.
16. HYAMS K., BOURGEOIS A., MERRELL B., ROZMAJZL P., ESCAMILLA J., THORNTON S. - Diarrheal disease during operation desert storm. - N. Engl. J. Med., 325, 1423-1428, 1991.
17. SMITH H., LINGGOOD M. - Observation of the pathogenic properties of K88. Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhea. - J. Med. Microbiol., 4, 467-485, 1971.
18. BOEDEKER E. - Prospects oral vaccines for enteric bacterial infections. - In: Immunology and Immonopathology of the Liver and Gastrointestinal Tract, Tarjon S. and Shanahan F. Eds., Igaku-Shoin, New York and Tokyo, 1989, pp. 435-447.
19. LEVINE M. - Modern vaccines. - Lancet, I, 958-960, 1990.
20. BOEDEKER E., YOUNG C., COLLINS H., CHENEY C., LEVINE M. - Towards a vaccine for traveler's diarrhea, mucosally administered E. coli colonization factor antigens elicit a specific local immunoglobulin A response in isolated intestinal loops. - Gastroenterology, 82, 1020, 1982.
21. DELA CABADA F., EVANS D.G., EVANS D.J. - Immunoprotection against enterotoxigenic Escherichia coli diarrhea in rabbits peroral administration of purified colonization factor antigens I (CFA/I). - FEMS Microbiol. Lett., 11, 303-307, 1981.
22. LEVINE M., KAPER J., BLACK R., CLENETS M. - New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. - Microbiol. Rev., 47, 510-550, 1983.
23. SHOHAM H., COLLINS H., BERMAN S., YOUNG C., LEVINE M., BOEDEKER E. - Towards a vaccine for traveler's diarrhea: mucosal immunogenecity of E. coli colonization factor antigens (CFAs) sterilized by radiation or formalin. - Gastroenterology, 84, 1308, 1983.
24. LEVINE M. - Traveler's diarrhea: prospects for successful immunoprophylaxis. - Scand. J. Gastroenterology, 18, 121-134, 1983.
25. SCHMIDT M., KELLY E., TSENG L., BOEDEKER E. - Towards an oral E. coli pilus vaccine for traveler's diarrhea: susceptibility of purified colonization factor antigen/II to proteolytic digestion. - Gastroenterology, 88, 1575, 1985.
26. LEVINE M., MORRIS J., LOSONSKY G., BOEDEKER E., ROWE B. - Fimbriæ (pili) adhesions as vaccine. - In: Molecular Biology of Microbial Pathogenicity, Protein-Carbohydrate Interactions in Biological Systems, Lark D. et al. Eds., Academic Press, London, 1986, pp. 143-145.
27. LEVINE M., RISTAINO P., MARLEY G., SMYTH C., KNUTTON S., BOEDEKER E., BLACK R., YOUNG C., CLEMENTS M., CHENEY C., PATNAIK R. - Coli surface antigens 1 and 3 of colonization factor antigen II positive enterotoxigenic Escherichia coli: morphology, purification and immune responses in human. - Infect. Immun., 44, 409-420, 1984.
28. KREUTER J. - Evaluation of nanoparticles as drug delivery systems. I. Preparation methods. - Pharm. Acta Helv., 58, 196-209, 1983.
29. SCHACTERLE G., POLLACK R. - A simplified method for the quantitative assay of small amounts of protein in biologic material. - Analytical Biochemistry, 51, 654-655, 1973.
30. YOUNG C., LEVINE M., GRAIGE J., ROBINS P. - Microliter enzyme linked immune sorbent assay for IgG cholera antitoxin in humans: method correlation with rabbit skin vascular permeability factor technique. - Infect. Immune., 27, 492-496, 1980.
31. EL-EGAKEY M., SPEISER P. - Drug loading studies on ultrafine solid carriers by sorption procedures. - Pharm. Acta Helv., 57, 236-240, 1982.
32. BECK P., RESZKA R., FICHTNER I. - Influence of poly butylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumor models. - J. Microencapsul., 10, 101-114, 1993.
33. SCHWENDEMAN S., CARDAMONT M, BRANDEN M., KLIBANOV A., LANGER R. - Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-50.
34. TOBIO M., JESSICA, N., GUO Y., MVIVER J., ALONSO J. - A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. - Pharm. Res., 16, 682-688, 1999.
35. LAMPRECHT A., UBRICH N., HOMBREIRO M., LEHR C., HOFFMAN M., MAINCENT P. - Biodegradable monodispersed nanoparticles prepared by pressure homogenizationemulsification. - Int. J. Pharm., 5, 97-105, 1999.
36. NAJIB N., SULEIMAN M., MALAKH A. - Characterization of the in vitro release of ibuprofen from poly vinyl pyrrolidone solid dispersions. - Int. J. Pharm., 32, 229-236, 1986.
37. MARCHAL-HEUSSLER L., MAINCENT P., HOFFMAN M., SPITTLER J., COUVREUR P. - Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticles preparations. - Int. J. Pharm., 58, 115-122, 1990.
38. Fresta M., Puglisi G. - Association of netilmicin sulphate to poly(alkylcyanoacrylate) nanoparticles: factors influencing particle delivery behavior. - Drug Dev. Ind. Pharm., 20, 2227-2243, 1994.
39. ELDRIDGE J., GILLEY R., STAAS J., MOLDOVEANU Z., MEULBROEK J., TICE T. - Biodegradable microspheres: vaccine delivery system for oral immunization. - Cutt. Top. Mirobiol. Immunol., 146, 59-66, 1989.
40. BOCKMAN D., COOPER M. - Pinocytosis by epithelium associated with lymphoid follicles in the bursus of Fabricius, appendix and Peyer's Patches. An electron microscopic study. - Am. J. Anat., 136, 455-478, 1973.
41. DEFONTAINE L., APRAHAMIAN M., MICHEL C., HUMBERT W., DAMGE C. - Les plaques de Peyer: site préférentiel d'absorption d'un vecteur de médicaments chez le rat. - Gastroenterol. Cli. Biol., 13, A104 (Abstract), 1989.
42. MOLDOVEANU Z., STAAS J., COMPAS R., ELDRIDGE J. - Immune response to influenza virus in orally and systemically immunized mice. - Curr. Top. Microbiol. Immunol., 146, 91-99, 1989.
43. O'HAGAN D., PALIN K., DAVIS S., ARTUSSON P., SJOHOLM I. - Microparticles as potentially orally active immunological adjuvants. - Vaccine, 7, 421-424, 1989.
44. OGAWA T., SHIMAICHI H., HAMADA S. - Mucosal and system immune responses in BALB/C mice to bacteroids gingivalis fimbriae administered orally. - Infct. Immun., 57, 3466-3471, 1989.
45. RENTLE C., BOUWSTRA J., NAISBETT B., JUNGINGER H. - Niosomes as a novel peroral vaccine delivery system. - Int. J. Pharm., 186, 161-167, 1999.